Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BESTFIT: TNX-102 SL in Fibromyalgia
NCT01903265Phase 3Completed
- Sponsor
- Tonix Pharmaceuticals
- Start
- Sep 2013
- Primary completion
- Jul 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of Tonmya in fibromyalgia (FM), sponsored by Tonix Pharmaceuticals. Started Sep 2013; status: completed.
02
Drugs
Tonmya
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01903265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01903265.